Screening of hepatitis C virus infection in adult general population in Spain

European Journal of Gastroenterology and Hepatology - Tập 30 Số 9 - Trang 1077-1081 - 2018
Laura Gómez-Escolar Viejo1, Esther García-Planella1,2, Isabel Sáez Lloret3, Fernando Sánchez Ruano4, Inmaculada Clemente Paulino3, Cristina Quílez Ivorra1, Isabel Almenta Saavedra1, David M. Callejo Pérez1, Jaime Valverde de la Osa1
1Division of Gastroenterology, Hospital Marina Baixa de Villajoyosa
2fax: +34 966 859 800
3Centre de Salut Pública Benidorm
4Centre de Salut de Callosa d’En Sarrià, Alicante, Spain

Tóm tắt

Purpose The aim was to estimate seroprevalence and prevalence of hepatitis C virus (HCV) infection in a small health area of the Valencian Community, Spain. Patients and methods This is a descriptive cross-sectional study aimed at estimation of HCV infection prevalence in the whole adult population (25–70 years old), that is, a pilot study for an eventual population-based screening program. Results A total of 5849 participants aged 25–70 years (51% male) were invited to participate by regular mail. Overall, 143 letters were returned owing to errors in the addresses. Of 5706 participants, 2637 (46.2%) participated in the study. Rapid test of anti-HCV antibody detection was positive in 30 cases (HCV seroprevalence 1.14%, 95% confidence intervals: 0.73–1.55%). Of those, seven were not aware of their condition. Participants who had a positive result in the rapid test of anti-HCV detection were given a confirmatory test by enzyme immune assay, and all had a positive result. RNA-HCV determination by quantitative PCR in positive anti-HCV patients showed positive viremia in 13 (43.3%) cases, of which five were not aware of the disease. Of the 17 patients who had negative viremia, two were unaware of their HCV status, one was a carrier of anti-HCV and was already aware of his condition, and 14 had been previously treated with satisfactory results. Regarding fibrosis, of the seven patients who were unaware of HCV infection, none of them had significant fibrosis. Moreover, 26 (86.7%) anti-HCV positive patients were reported to have one or more risk factors for HCV infection. Conclusion HCV screening strategies applied to the general population are good means to diagnose and treat patients who are not aware of their infection, avoiding new transmissions as well as disease progression.

Từ khóa


Tài liệu tham khảo

Gower, 2014, Global epidemiology and genotype distribution of the hepatitis C virus infection, J Hepatol, 61, S45, 10.1016/j.jhep.2014.07.027

Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2095, 10.1016/S0140-6736(12)61728-0

2015, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 385, 117, 10.1016/S0140-6736(14)61682-2

Razavi, 2014, The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm, J Viral Hepatitis, 21, 34, 10.1111/jvh.12248

Spengler, 2017, Direct antiviral agents (DAAs) – a new age in the treatment of hepatitis C virus infection, Pharmacol Ther, 183, 118, 10.1016/j.pharmthera.2017.10.009

Bruguera, 2006, Hepatitis C En España, Med Clin, 127, 113, 10.1157/13090276

Bruggmann, 2014, Historical epidemiology of hepatitis C virus (HCV) in selected countries, J Viral Hepatitis, 21, 5, 10.1111/jvh.12247

2015, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, Lancet, 2, 161

Sacristán, 1996, Seroepidemiolgical study of hepatitis C virus infection in a general population from the región of La Rioja, Spain, Med Clin, 107, 331

García-Fulgueiras, 1996, Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults, Scan J Infect Dis, 28, 17, 10.3109/00365549609027143

Suárez, 1997, The prevalence of hepatitis A, B and C viral markers in the population of Gijón between 26 and 65 years old, Gastronterol Hepatol, 20, 347

Riestra, 2001, Prevalence of hepatitis C virus infection in the general population of northern Spain, Eur J Gastroenterol Hepatol, 13, 477, 10.1097/00042737-200105000-00003

Domínguez, 2001, Community-based seroepidemiological survey of HCV infection in Catalonia, Spain, J Med Virol, 65, 688, 10.1002/jmv.2091

Solà, 2002, Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study, Med Clin, 119, 90

López-Izquierdo, 2007, Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y León (Spain), Enferm Infecc Microbiol Clin, 25, 317, 10.1157/13102267

Calleja-Panero, 2013, Prevalence of viral hepatitis (B and C) serological markers in healthy working population, Rev Esp Enferm Dig, 105, 249, 10.4321/S1130-01082013000500002

García Comas, 2015, Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009, J Med Virol, 87, 697, 10.1002/jmv.24219

Aguinaga, 2017, Estimación de la prevalencia de infección diagnosticada y no diagnosticada por el virus de la hepatitis C en Navarra, 2014-2016, Enferm Infecc Mircrobiol Clin, 36, 325, 10.1016/j.eimc.2016.12.008

Lavin, 2017, Prevalence ot hepatitis C in the Spanish population. The PREVHEP study (Ethon Cohort), J Hepatol, 66, S272, 10.1016/S0168-8278(17)30857-7

Pallarés, 2017, Pilot validation of a rapid test in oral fluid for population screening of hepatitis C virus infection, J Hepatol, S1, 1

Ziol, 2005, Noninvasive assessment of liver stiffness in patients with chronic hepatitis C, Hepatology, 41, 48, 10.1002/hep.20506

Hofstraat, 2017, Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review, Epidemiol Infect, 145, 2873, 10.1017/S0950268817001947

1998, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCVrelated chronic disease, MMWR Recomm Rep, 47, 1

2012, Recommendations for the identification of chronic hepatitis C virus (HCV) among persons born during 1945–1965, MMWR Recomm Rep, 61, 1

Denniston, 2012, Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008, Hepatology, 55, 1652, 10.1002/hep.25556

Mena, 2014, Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing, PLoS One, 9, e113062, 10.1371/journal.pone.0113062

Rein, 2012, The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings, Ann Intern Med, 156, 263, 10.7326/0003-4819-156-4-201202210-00378

Buti, 2017, Elimination of hepatitis C in Spain: adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System, Med Clin (Barc), 148, 277, 10.1016/j.medcli.2016.12.018

Thông tin
Thông tin xuất bản

European Journal of Gastroenterology and Hepatology

Tập 30 Số 9

1077-1081

Thông tin tác giả